0001415889-24-003721.txt : 20240214
0001415889-24-003721.hdr.sgml : 20240214
20240214161521
ACCESSION NUMBER: 0001415889-24-003721
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191008
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN JEREMY M
CENTRAL INDEX KEY: 0001256153
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 24638383
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
4/A
1
form4a-02142024_040202.xml
X0508
4/A
2019-10-08
2019-10-10
0001636651
Ovid Therapeutics Inc.
OVID
0001256153
LEVIN JEREMY M
C/O OVID THERAPEUTICS INC.
441 NINTH AVENUE, 14TH FLOOR
NEW YORK
NY
10001
true
true
false
false
CEO
0
Common Stock
2019-09-20
4
G
0
465116
0
D
0
I
See Footnote
The shares were transferred to two family trusts for the benefit of the Reporting Person's adult children as part of generational estate planning. These transfers were made for no consideration. The Reporting Person does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares. These transactions are being reported late due to an inadvertent administrative error.
Prior to the gift, the reportable securities were owned directly by DSL-EAL Holdings LLC (the "LLC"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein.
/s/ Danielle Mann for Jeremy M. Levin by POA
2024-02-14